# IRLAB Therapeutics – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/irlab-therapeutics
Company JSON: https://spela.port0.org/company/irlab-therapeutics/company.json
Documents JSON: https://spela.port0.org/company/irlab-therapeutics/documents.json
Updated: 2026-08-07T04:27:38Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/irlab-therapeutics/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/irlab-therapeutics/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/irlab-therapeutics/market/manifest.json
- Nasdaq instrumentidentitet JSON: https://spela.port0.org/company/irlab-therapeutics/market/instrument.json
- MFN manifest JSON: https://spela.port0.org/company/irlab-therapeutics/market/mfn-manifest.json
- Nasdaq rapportmanifest JSON: https://spela.port0.org/company/irlab-therapeutics/market/nasdaq-reports-manifest.json

## Financial reports
- Page: https://spela.port0.org/company/irlab-therapeutics/reports
- JSON: https://spela.port0.org/company/irlab-therapeutics/reports/reports.json
- 2026 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2026: https://view.news.eu.nasdaq.com/view?id=bac2e7970971b6dee153f44604e4bfd08&lang=sv&src=listed
- 2025 Årsredovisning | Nasdaq Nordic | Årsredovisning 2025: https://view.news.eu.nasdaq.com/view?id=baa536c9dcacc3328fe02db5b0797b2c0&lang=sv&src=listed
- 2025 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2025: https://view.news.eu.nasdaq.com/view?id=b3681710b0170c4d7a81e9bf501ddb949&lang=sv&src=listed
- 2025 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2025: https://view.news.eu.nasdaq.com/view?id=b7929cb4c562f8434dcd68ed2a24aa5eb&lang=sv&src=listed
- 2025 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2025: https://view.news.eu.nasdaq.com/view?id=b3ead9f8ea853de98bb4a89098c78b2e8&lang=sv&src=listed
- 2025 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2025: https://view.news.eu.nasdaq.com/view?id=b4dbcd7fac0277fe4ff017a6db8554524&lang=sv&src=listed
- 2024 Årsredovisning | Nasdaq Nordic | Årsredovisning 2024: https://view.news.eu.nasdaq.com/view?id=b6333f0fe3eb45a89c1a0c519e8add71a&lang=sv&src=listed
- 2024 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2024: https://view.news.eu.nasdaq.com/view?id=b62c405c57bf2b81dac0fd7ccc752fdaa&lang=sv&src=listed
- 2024 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2024: https://view.news.eu.nasdaq.com/view?id=b75f15362c96e9c2427dcba54fa88f2c9&lang=sv&src=listed
- 2024 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2024: https://view.news.eu.nasdaq.com/view?id=b1a932c7e411d1522abffc928eb926ea1&lang=sv&src=listed
- 2024 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2024: https://view.news.eu.nasdaq.com/view?id=b382108fa4f0ea3918dfb1ad2b2086216&lang=sv&src=listed
- 2023 Årsredovisning | Nasdaq Nordic | Årsredovisning 2023: https://view.news.eu.nasdaq.com/view?id=b2faf8be30c856129c7430454064a4244&lang=sv&src=listed
- 2023 Q4 | Nasdaq Nordic | Kvartalsrapport Q4 2023: https://view.news.eu.nasdaq.com/view?id=b8b3bfc3c4952ac57e1edd96aff953504&lang=sv&src=listed
- 2023 Q3 | Nasdaq Nordic | Kvartalsrapport Q3 2023: https://view.news.eu.nasdaq.com/view?id=b437a375968b71a74800487bc89143c8d&lang=sv&src=listed
- 2023 Q2 | Nasdaq Nordic | Kvartalsrapport Q2 2023: https://view.news.eu.nasdaq.com/view?id=b4a1cd1568099a10abdbf6b456e09cec4&lang=sv&src=listed
- 2023 Q1 | Nasdaq Nordic | Kvartalsrapport Q1 2023: https://view.news.eu.nasdaq.com/view?id=b47ae27d3a5657ed942eee368ce3a4c0f&lang=sv&src=listed

## Finansinspektionen
- Page: https://spela.port0.org/company/irlab-therapeutics/finansinspektionen
- Summary: https://spela.port0.org/company/irlab-therapeutics/finansinspektionen/summary.json
- Insider transactions CSV: https://spela.port0.org/company/irlab-therapeutics/finansinspektionen/insider-transactions.csv
- Insider transactions JSON: https://spela.port0.org/company/irlab-therapeutics/finansinspektionen/insider-transactions.json
- Current short positions: https://spela.port0.org/company/irlab-therapeutics/finansinspektionen/short-current.json
- Historical short positions: https://spela.port0.org/company/irlab-therapeutics/finansinspektionen/short-history.json

## Full-text source documents
- Nasdaq Nordic | Kvartalsrapport Q1 2026: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2025: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/part-001.html
  - HTML part 2: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2025/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2025: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2025: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2025: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2025: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2024: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/part-001.html
  - HTML part 2: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2024/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2024: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2024: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2024: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2024: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt
- Nasdaq Nordic | Årsredovisning 2023: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/part-001.html
  - HTML part 2: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-arsredovisning-2023/part-002.html
- Nasdaq Nordic | Kvartalsrapport Q4 2023: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q3 2023: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q2 2023: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt
- Nasdaq Nordic | Kvartalsrapport Q1 2023: https://spela.port0.org/company/irlab-therapeutics/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt
- MFN | MFN bolagssida och bolagsmetadata: https://spela.port0.org/company/irlab-therapeutics/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt